Maven Securities LTD Medicenna Therapeutics Corp. Transaction History

Maven Securities LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.83 - $1.78 $124,500 - $267,000	150,000 New	150,000 $1.24 Million
Q3 2021 Nov 15, 2021	SELL	$1.91 - $3.05 $151,115 - $241,309	-79,118 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.97 - $4.28 $322,752 - $465,111	-108,671 Reduced 57.87%	79,118 $234,000
Q1 2021 May 17, 2021	BUY	$3.5 - $4.56 $657,261 - $856,317	187,789 New	187,789 $749,000

863K

Ticker MDNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,637,504
Market Cap $21.6M
Description
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.